Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19
Journal of International Immunopharmacology. 2020 Sep;86:106749. doi: 10.1016/j.intimp.2020.106749.
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Journal of International Immunopharmacology. 2020 Sep;86:106749. doi: 10.1016/j.intimp.2020.106749.
Int. J. Mol. Sci. 2020; 21:6632 DOI: 10.3390/ijms21186632
Arthritis Res Ther. 2020;22(1):193
Annals of the Rheumatic Diseases, May 2020
Arthritis Care Res (Hoboken) 2020;72(8):1112-1121
Annals of the Rheumatic Diseases 2020;79:778-786
Rheumatol Ther 2020 doi.org/10.1007/s40744-020-00209-4
Arthritis Res Ther 2020;22:142
RMD Open 2020;6:e001174 doi:10.1136/rmdopen-2020-001174